Total Assets: The sum of all assets on a company's balance sheet.
Regeneron Pharmaceuticals, Inc. (REGN) had Total Assets of $40.56B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.88B |
|
$844.60M |
|
$584.60M |
|
$3.30B |
|
$3.00B |
|
$879.90M |
|
$163.80M |
|
$1.04B |
|
$1.04B |
|
$844.60M |
|
$844.60M |
|
$844.60M |
|
$844.60M |
|
$879.90M |
|
$1.02B |
|
104.60M |
|
108.60M |
|
$8.16 |
|
$7.78 |
|
| Balance Sheet Financials | |
$18.02B |
|
$5.12B |
|
$22.54B |
|
|
Total Assets |
$40.56B |
$4.37B |
|
$2.71B |
|
$4.93B |
|
$9.30B |
|
$31.26B |
|
$30.00B |
|
$31.26B |
|
105.70M |
|
| Cash Flow Statement Financials | |
$4.98B |
|
$-629.10M |
|
$-3.72B |
|
$2.49B |
|
$3.12B |
|
$634.70M |
|
$993.70M |
|
$-370.30M |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.13 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
84.95% |
|
22.65% |
|
22.65% |
|
-- |
|
26.87% |
|
21.74% |
|
$4.08B |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.18 |
|
0.68 |
|
133.02 |
|
2.70% |
|
2.82% |
|
2.08% |
|
2.49% |
|
$295.71 |
|
$37.57 |
|
$45.85 |
|